Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Nan (Ln) Li acquired 1,111,111 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were acquired at an average cost of $18.00 per share, for a total transaction of $19,999,998.00. Following the acquisition, the director directly owned 3,333,516 shares of the company’s stock, valued at $60,003,288. This trade represents a 50.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.
Odyssey Therapeutics Stock Up 0.2%
Shares of ODTX opened at $17.94 on Thursday. Odyssey Therapeutics, Inc. has a 52-week low of $15.35 and a 52-week high of $20.30.
See Also
- Five stocks we like better than Odyssey Therapeutics
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
